The study of acute and subchronic oral toxicity of medicinal drug «Enrocolitrim» on laboratory animals

Author:

Abramov S. V.1ORCID,Balyshev A. V.2ORCID,Golovin V. V.1ORCID,Starikov N. M.3ORCID,Zhuravleva M. S.1ORCID

Affiliation:

1. «OZOS» Ltd.

2. The Volga Region Research Institute of Manufacture and Processing of Meat-and-Milk Production

3. Ural Federal Agrarian Scientific Research Centre, Ural Branch of the Russian Academy of Sciences

Abstract

Relevance. The results of the study of the oral toxicity of the medicinal product for veterinary use «Enrocolitrim» on laboratory rodents are presented. Studies of acute toxicity in mice and rats with the determination of the hazard class are described, as well as data on the study of subchronic toxicity of the drug for 14 days in laboratory rats are presented.Methods. To determine the acute toxicity of the drug, 36 outbred rats and 50 outbred mice were used. «Enrocolytrim» was administered using an intragastric tube at doses that allow revealing a dose-dependent effect to assess LD50. Toxicity parameters were calculated according to the method of Kerber, Miller and Teintner, the nature and severity of signs of animal intoxication were visually assessed for 14 days. In a subchronic experiment, the study drug «Enrokolitrim» was studied on 40 outbred rats, of which 3 experimental and 1 control groups were formed. During the experiment, the rodents were weighed, signs of intoxication were recorded, and blood samples were taken for morphological and biochemical analyzes. Dead and euthanized animals were subjected to autopsy.Results. The obtained LD50 values with a single oral administration of the drug «Enrocolitrim» to rats and mice allowed it to be assigned the 4th hazard class – lowh–azard substances (GOST 12.1.007-76). In a subchronic 14-day experiment on rats, it was found that the dose of «Enrocolitrim» 1243 mg/kg with intragastric administration is toxic, and doses of 621.5 mg/kg and 248.6 mg/kg are inactive (safe).

Publisher

Agrarian Science

Subject

General Medicine

Reference12 articles.

1. Yakovlev S.V. et. al. Strategy and tactics of the rational use of antimicrobial drugs in outpatient practice. Eurasian clinical guidelines (2016). Handbook for Practitioners Doctors. 2017; (1): 6–53 (In Russian). https://www.elibrary.ru/zcndqp

2. Kolbin A.S., Sidorenko S.V., Balykina Yu.E. Research in the field of new antibacterial agents. Are there any prospects? Pediatric Pharmacology. 2010; 7(5): 12–16 (In Russian). https://www.elibrary.ru/mwiedf

3. Simjee Sh., Doole R., Kozlov R.S. Responsible use of antibiotics in food animals. Clinical Microbiology and Antimicrobial Chemotherapy. 2016; 18(3): 186–190 (In Russian). https://www.elibrary.ru/wlxcoh

4. Kashkovskaya L.M. “Doxylox Feed” is a balanced approach to the therapy of bacterial infections. Svinovodstvo. 2018; (5): 49 (In Russian). https://www.elibrary.ru/xvlycl

5. Birukova N.P., Rusakov S.V., Napalkova V.V. General principles of preclinical safety evaluation of pharmacological drugs for veterinary use. The Veterinarian. 2018; (1): 3–9 (In Russian). https://www.elibrary.ru/yszkju

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3